HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model

Neurobiol Dis. 2008 Sep;31(3):433-41. doi: 10.1016/j.nbd.2008.05.020. Epub 2008 Jun 14.

Abstract

Hypoxia-inducible factor-1alpha (HIF-1alpha) has been considered as a regulator of both prosurvival and prodeath pathways in the nervous system. The present study was designed to elucidate the role of HIF-1alpha in neonatal hypoxic-ischemic (HI) brain injury. Rice-Vannucci model of neonatal hypoxic-ischemic brain injury was used in seven-day-old rats, by subjecting unilateral carotid artery ligation followed by 2 h of hypoxia (8% O2 at 37 degrees C). HIF-1alpha activity was inhibited by 2-methoxyestradiol (2ME2) and enhanced by dimethyloxalylglycine (DMOG). Results showed that 2ME2 exhibited dose-dependent neuroprotection by decreasing infarct volume and reducing brain edema at 48 h post HI. The neuroprotection was lost when 2ME2 was administered 3 h post HI. HIF-1alpha upregulation by DMOG increased the permeability of the BBB and brain edema compared with HI group. 2ME2 attenuated the increase in HIF-1alpha and VEGF 24 h after HI. 2ME2 also had a long-term effect of protecting against the loss of brain tissue. The study showed that the early inhibition of HIF-1alpha acutely after injury provided neuroprotection after neonatal hypoxia-ischemia which was associated with preservation of BBB integrity, attenuation of brain edema, and neuronal death.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • 2-Methoxyestradiol
  • Amino Acids, Dicarboxylic / pharmacology
  • Amino Acids, Dicarboxylic / therapeutic use
  • Animals
  • Animals, Newborn
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / metabolism
  • Brain / drug effects*
  • Brain / metabolism*
  • Brain / physiopathology
  • Brain Edema / drug therapy
  • Brain Edema / metabolism
  • Brain Edema / physiopathology
  • Brain Infarction / drug therapy
  • Brain Infarction / metabolism
  • Brain Infarction / physiopathology
  • Cytoprotection / drug effects
  • Cytoprotection / physiology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Estradiol / analogs & derivatives
  • Estradiol / pharmacology
  • Estradiol / therapeutic use
  • Female
  • Hypoxia-Inducible Factor 1, alpha Subunit / antagonists & inhibitors*
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism*
  • Hypoxia-Ischemia, Brain / drug therapy*
  • Hypoxia-Ischemia, Brain / metabolism*
  • Hypoxia-Ischemia, Brain / physiopathology
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use
  • Rats
  • Tubulin Modulators / pharmacology
  • Vascular Endothelial Growth Factor A / drug effects
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Amino Acids, Dicarboxylic
  • Enzyme Inhibitors
  • Hif1a protein, rat
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Neuroprotective Agents
  • Tubulin Modulators
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, rat
  • Estradiol
  • 2-Methoxyestradiol
  • oxalylglycine